These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33165625)

  • 21. Graves' disease-induced immune thrombocytopenic purpura in an African female: a case report.
    Agyapong KO; Folson AA; Fiador K; Kootin-Sanwu C; Tufuor M; Bampoh SA; Fiscian H; Wonkyi R
    J Med Case Rep; 2023 Apr; 17(1):122. PubMed ID: 37016396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hashimoto's thyroiditis following Graves' disease.
    Umar H; Muallima N; Adam JM; Sanusi H
    Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.
    Gudbrandsdottir S; Frederiksen H; Hasselbalch H
    Platelets; 2012; 23(6):423-9. PubMed ID: 22185370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune Hepatitis Associated with Immune Thrombocytopenic Purpura.
    Ito A; Yoshizawa K; Fujimori K; Morita S; Shigeno T; Maejima T
    Intern Med; 2017; 56(2):143-147. PubMed ID: 28090042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis.
    Hymes K; Blum M; Lackner H; Karpatkin S
    Ann Intern Med; 1981 Jan; 94(1):27-30. PubMed ID: 6893793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet antibodies and their correlation with clinical findings in childhood immune thrombocytopenic purpura.
    Yildirmak Y; Yanikkaya-Demirel G; Palanduz A; Kayaalp N
    Acta Haematol; 2005; 113(2):109-12. PubMed ID: 15802889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Helicobacter pylori in Patients with Immune Thrombocytopenia.
    Vanegas YAM; Vishnu P
    Hamostaseologie; 2019 Aug; 39(3):279-283. PubMed ID: 30891714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.
    Watanabe R; Tabayashi T; Tomikawa T; Sagawa M; Anan-Nemoto T; Kimura Y; Takahashi Y; Tokuhira M; Otaki S; Oi H; Sawano M; Sugiyama S; Kizaki M
    Int J Hematol; 2017 Jan; 105(1):100-103. PubMed ID: 27709451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombopoetin receptor agonist therapy in thrombocytopenia: ITP and beyond.
    Taylor A; Westwood JP; Laskou F; McGuckin S; Scully M
    Br J Haematol; 2017 May; 177(3):475-480. PubMed ID: 28295201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
    Tarantino MD; Fogarty PF; Shah P; Brainsky A
    Platelets; 2015; 26(1):93-6. PubMed ID: 24433306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithyroid treatment improves thrombocytopenia in a young patient with graves' disease.
    Faienza MF; Palmieri VV; Chiarito M; Lassandro G; Giordano P
    Acta Biomed; 2020 Nov; 91(4):e2020194. PubMed ID: 33525304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.
    Doobaree IU; Newland A; McDonald V; Nandigam R; Mensah L; Leroy S; Seesaghur A; Patel H; Wetten S; Provan D
    Eur J Haematol; 2019 May; 102(5):416-423. PubMed ID: 30758874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum leptin levels in patients with idiopathic thrombocytopenic purpura.
    Zhan M; Zhao H; Yang R; Han ZC
    Eur J Haematol; 2004 May; 72(5):348-52. PubMed ID: 15059070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim.
    Al-Samkari H; Van Cott EM; Kuter DJ
    Ann Hematol; 2019 Mar; 98(3):581-588. PubMed ID: 30446804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
    Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
    Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia.
    Jurczak W; Chojnowski K; Mayer J; Krawczyk K; Jamieson BD; Tian W; Allen LF
    Br J Haematol; 2018 Nov; 183(3):479-490. PubMed ID: 30191972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombocytopenia in newborn infants caused by autoimmune thrombocytopenic purpura in their mothers].
    Mordasewicz-Goliszewska M
    Wiad Lek; 1992 Apr; 45(7-8):270-4. PubMed ID: 1462587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura.
    Abbasi SY; Milhem M; Zaru L
    Ann Hematol; 2008 Jun; 87(6):459-62. PubMed ID: 18265983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
    Wall JR; Chartier B
    J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.